Molecular genetics of testicular cancer: What does the clinician need to know?

Dr Katherine Nathanson - University of Pennsylvania, Philadelphia, USA
Molecular genetics of testicular cancer: What does the clinician need to know? ( Dr Katherine Nathanson - University of Pennsylvania, Philadelphia, USA )
8 Jan 2016

ASCO GU 2016: Highlights

Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA
ASCO GU 2016: Highlights ( Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA )
8 Jan 2016

Atezolizumab for platinum-treated locally advanced or metastatic urothelial carcinoma

Dr Jean Hoffman-Censits - Kimmel Cancer Center, Philadelphia, USA
Atezolizumab for platinum-treated locally advanced or metastatic urothelial carcinoma ( Dr Jean Hoffman-Censits - Kimmel Cancer Center, Philadelphia, USA )
8 Jan 2016

Healthcare and QoL burden of symptomatic skeletal events in CRPC with bone mets

Dr Rana McKay - Dana-Farber Cancer Institute, Boston, USA
Healthcare and QoL burden of symptomatic skeletal events in CRPC with bone mets ( Dr Rana McKay - Dana-Farber Cancer Institute, Boston, USA )
8 Jan 2016

Regular aspirin use may reduce risk of dying from prostate cancer

Dr Christophe Allard - Massachusetts General Hospital, Boston, USA
Regular aspirin use may reduce risk of dying from prostate cancer ( Dr Christophe Allard - Massachusetts General Hospital, Boston, USA )
8 Jan 2016

Link between non-aspirin NSAID use and risk of developing renal cell cancer

Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA
Link between non-aspirin NSAID use and risk of developing renal cell cancer ( Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA )
7 Jan 2016

Brentuximab vedotin as salvage therapy for men with relapsed germ-cell tumours

Dr Andrea Necchi - Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Brentuximab vedotin as salvage therapy for men with relapsed germ-cell tumours ( Dr Andrea Necchi - Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy )
7 Jan 2016

Actionable targets in patients with cisplatin-resistant advanced germ cell tumours

Dr Aditya Bagrodia - Memorial Sloan Kettering New York, USA
Actionable targets in patients with cisplatin-resistant advanced germ cell tumours ( Dr Aditya Bagrodia - Memorial Sloan Kettering New York, USA )
7 Jan 2016

What does the iManageCancer project hope to achieve?

Prof Gordon McVie - ecancer Managing Editor
What does the iManageCancer project hope to achieve? ( Prof Gordon McVie - ecancer Managing Editor )
23 Dec 2015

PCA3 test for prostate cancer in Africa

Dr Imane Abdellaoui Maane - Moroccan Foundation for Advanced Science, Innovation and Research
PCA3 test for prostate cancer in Africa ( Dr Imane Abdellaoui Maane - Moroccan Foundation for Advanced Science, Innovation and Research )
8 Dec 2015

Detecting uterine cancers in Africa

Prof Leon Snyman - University of Pretoria, Pretoria, South Africa
Detecting uterine cancers in Africa ( Prof Leon Snyman - University of Pretoria, Pretoria, South Africa )
8 Dec 2015

Chemoprevention in breast cancer and possible vaccine for prostate cancer

Dr Leslie Ford - National Cancer Institute, Rockville, USA
Chemoprevention in breast cancer and possible vaccine for prostate cancer ( Dr Leslie Ford - National Cancer Institute, Rockville, USA )
7 Dec 2015